Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2002-07-25
2010-02-23
Kosar, Andrew D (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S535000, C435S068100
Reexamination Certificate
active
07666830
ABSTRACT:
Protein hydrolyzates are used for prevention of bacterial overgrowth. In addition it was shown in sucklings mammals that specific protein hydrolyzates promote an intestinal flore pattern which is similar to the one of mammals raised by their mother. Other advantages are that the hydrolyzate is easier to obtain and simpler to administrate than treatment of bacterial overgrowth with the aid of active principles.
REFERENCES:
patent: 5039532 (1991-08-01), Jost et al.
patent: 5055446 (1991-10-01), Alexander et al.
patent: 5178898 (1993-01-01), Juchem
patent: 5230902 (1993-07-01), Gold et al.
patent: 5405637 (1995-04-01), Martinez et al.
patent: 5531989 (1996-07-01), Paul
patent: 5661123 (1997-08-01), Stalker et al.
patent: 5821217 (1998-10-01), Forse et al.
patent: 6733770 (2004-05-01), Garcia-Rodenas et al.
patent: 6887850 (2005-05-01), Fuchs et al.
patent: 2845430 (1979-04-01), None
patent: 488011 (1992-06-01), None
patent: 0 626 177 (1994-11-01), None
patent: 0 671 126 (1995-09-01), None
patent: 1034704 (2000-09-01), None
patent: WO 99/13738 (1999-03-01), None
patent: WO 200054603 (2000-09-01), None
N. Chayen, “Protein crystallography: the human genome in 3-D.” Physics World (1998) 8 pages.
H. Berman, et al. American Scientist (2002) 90, pp. 350-359.
M. Tomita, et al. J. Dairy Sci. (1991) 74, pp. 4137-4142.
W. Brink. “Lactoferrin: The Bioactive peptide that fights disease.” LifeExtension Magazine (2000), 7 pages.
K. Yamauchi, et al. Infect. Immun. (1993) 61(2), pp. 719-728.
PUBMED Accession No. AAA30617. Apr. 27, 1993, accessed Aug. 14, 2006. 1 page.
Pepsin Digest of AAA30617 using “Peptide Cutter” by ExPASy. <<http://www.expasy.org/cgi-bin/peptidecutter/peptidecutterpl>> accessed Aug. 14, 2006. 6 pages.
H. Saito, et al. J. Dairy Sci. (1991) 74, pp. 3724-3730.
J. Rudinger. In: Peptide Hormones, JA Parsons, Ed. (1976) 1-7.
Kops et al. article entitled “Partially Purified Soy Hydrolysates Retard Proliferation and Inhibit Bacteria Translocation in Cultured C2BBe Cells”American Society for Nutritional Sciences, 1997, pp. 1744-1751.
Teraguchl et al. article entitled “Orally Administered Bovine Lactoferrin Inhibits Bacterial Translocation in Mice Fed Bovine Milk” Applied and Environmental Microbiology, Nov. 1995, vol. 61, No. 11, pp. 4131-4134.
Ballevre Olivier
Garcia-Rodenas Clara L.
Rochat Florence
K&L Gates LLP
Kosar Andrew D
Nestec S.A.
LandOfFree
Nutritional composition preventing bacterial overgrowth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nutritional composition preventing bacterial overgrowth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nutritional composition preventing bacterial overgrowth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4210527